Search by Drug Name or NDC

    NDC 66215-0501-15 OPSUMIT 10 mg/1 Details

    OPSUMIT 10 mg/1

    OPSUMIT is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Actelion Pharmaceuticals US, Inc.. The primary component is MACITENTAN.

    Product Information

    NDC 66215-0501
    Product ID 66215-501_fe1c280f-5053-ee0f-e053-6294a90a1489
    Associated GPIs 40160050000320
    GCN Sequence Number 071567
    GCN Sequence Number Description macitentan TABLET 10 MG ORAL
    HIC3 B1B
    HIC3 Description PULMONARY ANTI-HTN, ENDOTHELIN RECEPTOR ANTAGONIST
    GCN 35443
    HICL Sequence Number 040677
    HICL Sequence Number Description MACITENTAN
    Brand/Generic Brand
    Proprietary Name OPSUMIT
    Proprietary Name Suffix n/a
    Non-Proprietary Name macitentan
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, FILM COATED
    Route ORAL
    Active Ingredient Strength 10
    Active Ingredient Units mg/1
    Substance Name MACITENTAN
    Labeler Name Actelion Pharmaceuticals US, Inc.
    Pharmaceutical Class Endothelin Receptor Antagonist [EPC], Endothelin Receptor Antagonists [MoA]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA204410
    Listing Certified Through 2024-12-31

    Package

    NDC 66215-0501-15 (66215050115)

    NDC Package Code 66215-501-15
    Billing NDC 66215050115
    Package 1 BLISTER PACK in 1 CARTON (66215-501-15) / 15 TABLET, FILM COATED in 1 BLISTER PACK
    Marketing Start Date 2013-11-04
    NDC Exclude Flag N
    Pricing Information N/A